Together Pharma Income Statement

Financials in millions ILS. Fiscal year is January - December.

Millions ILS. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	109.63	96.05	91.01	31.23	12.03
Revenue Growth (YoY)	14.13%	5.55%	191.42%	159.67%	7.16%
Cost of Revenue	78.14	78.54	56.38	37.12	14.2
Gross Profit	31.49	17.51	34.62	-5.89	-2.17
Selling, General & Admin	16.26	14.24	12.53	11.61	9.55
Other Operating Expenses	-	-	-	2.27	-1.71
Operating Expenses	16.26	14.24	12.53	13.88	9.28
Operating Income	15.23	3.27	22.09	-19.77	-11.46
Interest Expense	-6.73	-9.38	-19.59	-17.2	-14.8
Interest & Investment Income	-	4.32	-	-	10.88
Earnings From Equity Investments	-	-	-0.25	-0	-
Currency Exchange Gain (Loss)	-2.87	0.48	0.54	1.76	-0.41
Other Non Operating Income (Expenses)	-0.75	-0.9	-1.25	-1.11	0.01
EBT Excluding Unusual Items	4.87	-2.21	1.54	-36.33	-15.78
Pretax Income	4.87	-2.21	1.54	-36.33	-15.12
Income Tax Expense	2.96	-0.59	4.07	-0.85	-
Earnings From Continuing Operations	1.92	-1.62	-2.53	-35.48	-15.12
Net Income to Company	1.92	-1.62	-2.53	-35.48	-15.12
Minority Interest in Earnings	-0.01	0.45	-1.78	1.96	1.34
Net Income	1.91	-1.17	-4.32	-33.52	-13.78
Net Income to Common	1.91	-1.17	-4.32	-33.52	-13.78
Shares Outstanding (Basic)	16	12	9	8	7
Shares Outstanding (Diluted)	16	12	9	8	7
Shares Change (YoY)	27.26%	41.39%	7.81%	18.96%	18.76%
EPS (Basic)	0.12	-0.09	-0.49	-4.15	-2.05
EPS (Diluted)	0.12	-0.09	-0.49	-4.18	-2.23
Free Cash Flow	5.17	1.37	13.97	-14.07	-20.17
Free Cash Flow Per Share	0.33	0.11	1.59	-1.73	-2.94
Gross Margin	28.72%	18.23%	38.04%	-18.86%	-18.07%
Operating Margin	13.89%	3.41%	24.28%	-63.30%	-95.27%
Profit Margin	1.74%	-1.22%	-4.74%	-107.35%	-114.55%
Free Cash Flow Margin	4.71%	1.43%	15.35%	-45.04%	-167.75%
EBITDA	21.28	8.93	27.62	-14.37	-6.14
EBITDA Margin	19.41%	9.30%	30.34%	-46.01%	-51.04%
D&A For EBITDA	6.05	5.66	5.52	5.4	5.32
EBIT	15.23	3.27	22.09	-19.77	-11.46
EBIT Margin	13.89%	3.41%	24.28%	-63.30%	-95.27%
Effective Tax Rate	60.64%	-	264.65%	-	-
Advertising Expenses	1.18	0.63	0.57	0.83	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.